FDA Approved Medical Products for:

Von Willebrand disease

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Antihemophilic factor (human)
Trade Name
(Manufacturer Name)
Alphanate®
(Grifols Biologicals Inc.)
Indication
The FDA has approved this product to be used in this manner.
For surgical and/or invasive procedures in patients with von Willebrand Disease (VWD) in whom desmopressin is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Antihemophilic factor/von Willebrand factor complex (human), dried, pasteurized
Trade Name
(Manufacturer Name)
Humate-P®
(CSL Behring)
Indication
The FDA has approved this product to be used in this manner.
(1) In adult patients for treatment and prevention of bleeding in hemophilia A (classic hemophilia) and (2) in adult and pediatric patients for treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Desmopressin acetate
Trade Name
(Manufacturer Name)
Stimate®
(CSL Behring)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with hemophilia A or von Willebrand's disease (type I) whose factor VIII coagulant activity level is greater than 5%.
More Information about this product Drug Information Portal

Generic Name Human Plasma Coagulation Factor VIII And Human Plasma Von Willebrand Factor
Trade Name
(Manufacturer Name)
Wilate(R)
(Octapharma USA, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated
More Information about this product Drug Information Portal